Khiron Life Sciences Corp. (KHRNF)

Overview

Khiron Life Sciences Corp. is a pioneer in the integration of medical and cannabis industries across Latin America and Europe. Established in 2012 and headquartered in Vancouver, Canada, the company focuses on leveraging the medical potential of cannabis to treat health conditions. Its operations are diversified into three segments: Health Services, Medical Cannabis Products, and Wellbeing Products, through which it delivers comprehensive healthcare and wellness solutions. By cultivating, producing, distributing, and exporting tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis, Khiron is at the forefront of addressing patient needs in regions with emerging cannabis markets.

Products and Services

• Health Services

  Operates a network of health centers and satellite clinics under the ILANS and Zerenia brands, providing specialized medical care and access to medical cannabis products for treatment.

• Medical Cannabis Products

  Focuses on the cultivation, production, distribution, and export of THC and CBD medical cannabis. These products are aimed at treating a variety of medical conditions, offering patients in Latin America and Europe quality-controlled and effective cannabis-based medications.

• Wellbeing Products

  Includes the development and distribution of CBD-based cosmeceutical products under the Kuida brand name. These skincare and wellness products leverage the beneficial properties of CBD to meet the growing demand for natural and effective cosmeceutical solutions.

• Zerenia Clinics

  Khiron operates the Zerenia clinic chain, with locations in Medellin and Peru, offering integrated healthcare services with a focus on the use of medical cannabis. These clinics serve as a pillar in Khiron’s strategy to bridge the gap between traditional healthcare and cannabis-based therapies, providing a controlled and professional environment for patient treatment.